Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients

NCT03881566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2021-04-29

No results posted yet for this study

Summary

This is an observational study to evaluate the diagnostic and prognostic value of presepsin in the critically-ill immunocompromise patients.

Conditions

Sponsors & Collaborators

  • Jongmin Lee

    lead OTHER

Principal Investigators

  • Jongmin Lee, M.D. · Seoul St. Mary's Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881566 on ClinicalTrials.gov